Keywords: aventis, submits, nda, once-daily, alegra, franco-german, drug

Aventis submits NDA for once-daily Alegra

Article | 05 January 2004

Print This

Franco-German drug major Aventis has announced the submission of a New Drug Application to the US Food and Drug Administration ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in